Literature DB >> 34282029

Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer.

Chiara Falcomatà1,2,3, Stefanie Bärthel1,2,3, Angelika Ulrich1,2, Roland Rad3,4,5, Günter Schneider6,4,7, Dieter Saur1,2,3,6, Sandra Diersch6, Christian Veltkamp1,2,3, Lena Rad1,2,3, Fabio Boniolo1,2,3, Myriam Solar8, Katja Steiger9,4, Barbara Seidler1,2,3,6, Magdalena Zukowska1,2,3,6, Joanna Madej1,2,3, Mingsong Wang1,2,3,6, Rupert Öllinger3,4,5, Roman Maresch3,4,5, Maxim Barenboim4,5,10, Stefan Eser1,2,6, Markus Tschurtschenthaler1,2,3, Arianeb Mehrabi11, Stephanie Roessler12, Benjamin Goeppert12, Alexander Kind13, Angelika Schnieke13, Maria S Robles14, Allan Bradley15, Roland M Schmid6, Marc Schmidt-Supprian3,4,16, Maximilian Reichert6,4,17, Wilko Weichert9,4, Owen J Sansom8,18, Jennifer P Morton8,18.   

Abstract

Biliary tract cancer ranks among the most lethal human malignancies, representing an unmet clinical need. Its abysmal prognosis is tied to an increasing incidence and a fundamental lack of mechanistic knowledge regarding the molecular basis of the disease. Here, we show that the Pdx1-positive extrahepatic biliary epithelium is highly susceptible toward transformation by activated PIK3CAH1047R but refractory to oncogenic KrasG12D. Using genome-wide transposon screens and genetic loss-of-function experiments, we discover context-dependent genetic interactions that drive extrahepatic cholangiocarcinoma (ECC) and show that PI3K signaling output strength and repression of the tumor suppressor p27Kip1 are critical context-specific determinants of tumor formation. This contrasts with the pancreas, where oncogenic Kras in concert with p53 loss is a key cancer driver. Notably, inactivation of p27Kip1 permits KrasG12D-driven ECC development. These studies provide a mechanistic link between PI3K signaling, tissue-specific tumor suppressor barriers, and ECC pathogenesis, and present a novel genetic model of autochthonous ECC and genes driving this highly lethal tumor subtype. SIGNIFICANCE: We used the first genetically engineered mouse model for extrahepatic bile duct carcinoma to identify cancer genes by genome-wide transposon-based mutagenesis screening. Thereby, we show that PI3K signaling output strength and p27Kip1 function are critical determinants for context-specific ECC formation. This article is highlighted in the In This Issue feature, p. 2945. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34282029      PMCID: PMC7612573          DOI: 10.1158/2159-8290.CD-21-0209

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  69 in total

1.  Genomic spectra of biliary tract cancer.

Authors:  Hiromi Nakamura; Yasuhito Arai; Yasushi Totoki; Tomoki Shirota; Asmaa Elzawahry; Mamoru Kato; Natsuko Hama; Fumie Hosoda; Tomoko Urushidate; Shoko Ohashi; Nobuyoshi Hiraoka; Hidenori Ojima; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Shinichi Miyagawa; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

Review 2.  Oncogenic PI3K deregulates transcription and translation.

Authors:  Andreas G Bader; Sohye Kang; Li Zhao; Peter K Vogt
Journal:  Nat Rev Cancer       Date:  2005-12       Impact factor: 60.716

3.  Translational medicine: Cancer lessons from mice to humans.

Authors:  David Tuveson; Douglas Hanahan
Journal:  Nature       Date:  2011-03-17       Impact factor: 49.962

4.  Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.

Authors:  Benjamin Goeppert; Carolin Konermann; Christopher Roman Schmidt; Olga Bogatyrova; Lea Geiselhart; Christina Ernst; Lei Gu; Natalia Becker; Manuela Zucknick; Arianeb Mehrabi; Mohammadreza Hafezi; Frederick Klauschen; Albrecht Stenzinger; Arne Warth; Kai Breuhahn; Marcus Renner; Wilko Weichert; Peter Schirmacher; Christoph Plass; Dieter Weichenhan
Journal:  Hepatology       Date:  2013-12-24       Impact factor: 17.425

5.  PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice.

Authors:  Roland Rad; Lena Rad; Wei Wang; Juan Cadinanos; George Vassiliou; Stephen Rice; Lia S Campos; Kosuke Yusa; Ruby Banerjee; Meng Amy Li; Jorge de la Rosa; Alexander Strong; Dong Lu; Peter Ellis; Nathalie Conte; Fang Tang Yang; Pentao Liu; Allan Bradley
Journal:  Science       Date:  2010-10-14       Impact factor: 47.728

Review 6.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

7.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

8.  A global double-fluorescent Cre reporter mouse.

Authors:  Mandar Deepak Muzumdar; Bosiljka Tasic; Kazunari Miyamichi; Ling Li; Liqun Luo
Journal:  Genesis       Date:  2007-09       Impact factor: 2.487

9.  Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.

Authors:  Jennifer P Morton; Paul Timpson; Saadia A Karim; Rachel A Ridgway; Dimitris Athineos; Brendan Doyle; Nigel B Jamieson; Karin A Oien; Andrew M Lowy; Valerie G Brunton; Margaret C Frame; T R Jeffry Evans; Owen J Sansom
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models.

Authors:  Sandra Diersch; Patrick Wenzel; Melanie Szameitat; Philipp Eser; Mariel C Paul; Barbara Seidler; Stefan Eser; Marlena Messer; Maximilian Reichert; Philipp Pagel; Irene Esposito; Roland M Schmid; Dieter Saur; Günter Schneider
Journal:  Oncotarget       Date:  2013-02
View more
  1 in total

Review 1.  Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.

Authors:  Man Li; Xueli Zhou; Wei Wang; Baoan Ji; Yu Shao; Qianyu Du; Jinghao Yao; Yan Yang
Journal:  J Clin Transl Hepatol       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.